BiPAD ® , LLC has engaged Tripoint Global Equities, LLC as a placement agent to initiate a $1.5M capital raise. This seed round will fund manufacturing for 510K FDA certification and beta testing of the BiPAD bipolar electrocautery forceps cord with integrated hand switch.
TriPoint Global Equities is a global investment bank focused on assisting fast growing companies.